ThomasFMcGarryMD

PubMed

• Development and validation of a machine learned algorithm to IDENTIFY functionally significant coronary artery disease.
  Thomas Stuckey, Frederick Meine, Thomas McMinn, Jeremiah P Depta, Brett Bennett, Thomas McGarry, William Carroll, David Suh, John A Steuter, Michael Roberts, Horace R ...> ;Frontiers in Cardiovascular Medicine. 2022 Jan 1
• 26 citations
  9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System
  Donald E. Cutlip, Kirk N. Garratt, Victor Novack, Mark Barakat, Perwaiz Meraj, Luc Maillard, Andrejs Erglis, Rajiv Jauhar, Jeffrey J. Popma, Robert C. Stoler, Sigmund ...> ;JACC. Cardiovascular Interventions. 2017 Jan 23
• Obese female patients have higher rates of lead dislodgement after ICD or CRT-D implantation.
  Kawata, H.,Patel, J.,McGarry, T.,Joshi, R.,Krummen, D.,Feld, G.,Birgersdotter-Green, U.> ;Int. J. Cardiol.. 2014 Feb 08
• Final 5-year results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion clinical trials of the TAXUS Liberté paclitaxel-eluting stent in de-novo...
  Ormiston JA, Charles O, Mann T, Hall JJ, McGarry T, Cannon LA, Webster MWI, Mishkel GJ, Underwood PL, Dawkins KD> ;Coron. Artery Dis.. 2013-01-01
• 8 citations
  Percutaneous coronary intervention with second-generation paclitaxel-eluting stents versus everolimus-eluting stents in United States contemporary practice (REWARDS TL...
  Ron Waksman, Magdi G.H. Ghali, Randy Goodroe, Thomas J. Ryan, Mark Turco, Michael E. Ring, Thomas F. McGarry, David Dobies, Nicolas Shammas, Daniel H. Steinberg, Stacy...> ;American Journal of Cardiology. 2012 Oct 15
• 41 citations
  Economic outcomes of percutaneous coronary intervention with drug‐eluting stents versus bypass surgery for patients with left main or three‐vessel coronary artery dise...
  David J. Cohen, Tara A. Lavelle, Ben van Hout, Haiyan Li, Yang Lei, Katherine Robertus, Duane S. Pinto, Elizabeth A. Magnuson, Thomas F. Mcgarry, Scott K. Lucas, Phill...> ;Catheterization and Cardiovascular Interventions. 2012 Feb 1
• 10 citations
  Improved strut coverage and less late incomplete apposition with thin-strut TAXUS Liberté vs. TAXUS Express: the importance of stent platform design for drug-eluting s...
  Neil J. Weissman, Mark Turco, John A. Ormiston, Tift Mann, Louis Cannon, Thomas F. McGarry, Mark Webster, Jack J. Hall, Michael J. Lucca, Gregory J. Mishkel, Chiung-Je...> ;Cardiovascular Revascularization Medicine. 2011 Jul 1
• 23 citations
  A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesion...
  Louis Cannon, Dean J. Kereiakes, Tift Mann, Jeffrey J. Popma, Michael R. Mooney, Gregory J. Mishkel, Tommy C. Lee, B Hadley Wilson, Thomas Stuckey, Steven Orlow, Thoma...> ;Eurointervention. 2011 Mar 1
• 26 citations
  TAXUS Liberté Attenuates the Risk of Restenosis in Patients With Medically Treated Diabetes Mellitus: Results From the TAXUS ATLAS Program
  Ehtisham Mahmud, John A. Ormiston, Mark Turco, Jeffrey J. Popma, Neil J. Weissman, Charles O'Shaughnessy, Tift Mann, Jack J. Hall, Thomas F. McGarry, Louis Cannon, Mar...> ;Jacc-cardiovascular Interventions. 2009 Mar 1
• 62 citations
  Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from ...
  Mark Turco, John A. Ormiston, Jeffrey J. Popma, Jack J. Hall, Tift Mann, Louis Cannon, Mark Webster, Gregory J. Mishkel, Charles O'Shaughnessy, Thomas F. McGarry, Laza...> ;Jacc-cardiovascular Interventions. 2008 Dec 1
• 45 citations
  Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial
  Stephen G. Ellis, Charles O'Shaughnessy, Steven L. Martin, Kenneth M. Kent, Thomas F. McGarry, Mark Turco, Dean J. Kereiakes, Jeffrey J. Popma, Mark I Friedman, Joerg ...> ;European Heart Journal. 2008 Jul 1
• 82 citations
  Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trial.
  Mark Turco, John A. Ormiston, Jeffrey J. Popma, Lazar Mandinov, Charles O'Shaughnessy, Tift Mann, Thomas F. McGarry, Chiung-Jen Wu, Charles Chan, Mark Webster, Jack J....> ;Journal of the American College of Cardiology. 2007 Apr 24
• 211 citations
  Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
  Gregg W. Stone, Stephen G. Ellis, Charles O'Shaughnessy, Steven L. Martin, Lowell F. Satler, Thomas F. McGarry, Mark Turco, Dean J. Kereiakes, Lynne Kelley, Jeffrey J....> ;JAMA. 2006 Mar 15
• 48 citations
  Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial).
  Eugenia Nikolsky, Edward J. Kosinski, Gregory J. Mishkel, Carey Kimmelstiel, Thomas F. McGarry, Roxana Mehran, Martin B. Leon, Mary E. Russell, Stephen G. Ellis, Gregg...> ;American Journal of Cardiology. 2005 Mar 15
• 68 citations
  The relationship of anticoagulation level and complications after successful percutaneous transluminal coronary angioplasty
  Thomas F. McGarry, Ronald S. Gottlieb, Joel Morganroth, Steven L. Zelenkofske, Hratch Kasparian, Peter R. Duca, Robert M. Lester, Thomas H Kreulen Md> ;American Heart Journal. 1992 Jun 1
• 5 citations
  NEW CONCEPTS IN THE APPROACH TO DIGITALIS THERAPY FOR ATRIAL FIBRILLATION.
  Leonard S. Dreifus, Thomas F. McGarry, Demetrios Kimbiris> ;Chest. 1963 Aug 1
• The venous and arterial pulse.
  Bernard L. Segal, Thomas F. McGarry> ;JAMA. 1963 Jul 27
• 19 citations
  Evaluation of the antiarrhythmic properties of antazoline. A preliminary study.
  S. Ronald Kline, Leonard S. Dreifus, Yoshio Watanabe, Thomas F. McGarry, William Likoff> ;American Journal of Cardiology. 1962 Apr 1
• Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia.
  Davidson, M. H., McGarry, T., Bettis, R., Melani, L., Lipka, L. J., LeBeaut, A. P., Suresh, R., Sun, S., Veltri, E. P.> ;J Am Coll Cardiol. 2002 Dec 18
• Propensity-matched patient-level comparison of the TAXUS Liberté and TAXUS element (ION) paclitaxel-eluting stents.
  Kereiakes, D. J., Cannon, L. A., Ormiston, J. A., Turco, M. A., Mann, T., Mishkel, G. J., McGarry, T., Wang, H., Underwood, P., Dawkins, K. D.> ;Am J Cardiol. 2011 Sep 15
• Join now to see all